We understand the challenges facing biosimilars, whether they are the first to be made available in a therapeutic area or are being launched into an established market. We advise on strategies and medical communication programs to drive clinician engagement and uptake of your biosimilar:
Established biosimilar defending its position
Launching and establishing a biosimilar
Marketing a portfolio of therapies
Impact specializes in supporting biosimilar brands at a global, regional, and country level. Our programs accelerate biosimilar adoption and provide differentiation in an increasingly competitive market: